← Back
Data updated: Mar 10, 2026
SOMERSET THERAP
Pharmaceuticals
SOMERSET THERAP is a generic drug manufacturer with 1 FDA-approved products.
2025
Since
1
Drugs
-
Trials
18
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
PRUCALOPRIDE SUCCINATE 2026-02-05
PRUCALOPRIDE SUCCINATE 2026-01-29
Labeling
PRUCALOPRIDE SUCCINATE 2026-01-16
PRUCALOPRIDE SUCCINATE 2025-08-07
PRUCALOPRIDE SUCCINATE 2025-06-24
PRUCALOPRIDE SUCCINATE 2025-06-24
PRUCALOPRIDE SUCCINATE 2025-06-24
PRUCALOPRIDE SUCCINATE 2025-06-24
PRUCALOPRIDE SUCCINATE 2025-06-24
PRUCALOPRIDE SUCCINATE 2025-06-24
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (1)
Company Info
- First Approval
- 2025-06-24
- Latest
- 2025-06-24
- Applications
- 1